Jérémy Bastid

Induction of EMT by Twist Proteins as a Collateral Effect of Tumor-Promoting Inactivation of Premature Senescence

Stéphane Ansieau, Jérémy Bastid, Agnès Doreau et al. · Cancer Cell · 2008 · 686 citations · Full text

Medicine, Cancer Growth, Epithelial-mesenchymal Interactions +11

Interleukin 17 acts in synergy with B cell–activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus

Agnès Doreau, Alexandre Belot, Jérémy Bastid et al. · Nature Immunology · 2009 · 446 citations

Immune Regulation, Immunology, Immune Dysregulation +17

Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies

Ivan Perrot, Henri‐Alexandre Michaud, Marc Giraudon-Paoli et al. · Cell Reports · 2019 · 404 citations · Full text

Cancer Immunosurveillance, Medicine, Immune Checkpoint Inhibitors +15

Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity

Jérémy Bastid, Anne Regairaz, Nathalie Bonnefoy et al. · Cancer Immunology Research · 2014 · 237 citations

Cd39 Enzymatic Function, T-regulatory Cell, Immunology +25

IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2

Stéphanie Cochaud, Jérôme Giustiniani, Clémence Thomas et al. · Scientific Reports · 2013 · 134 citations · Full text